solution by MARKET

Pharmaceutical Production Lines & Turnkey Factory Solutions for Tanzania

From IV solution filling lines and OSD plants to injectable systems and medical device machinery — GMP-compliant manufacturing infrastructure built for East Africa’s fastest-emerging pharmaceutical hub.

Market Overview

A Clear View of the Local Market Landscape

Tanzania has spent more than $1.5 billion on importing pharmaceutical products over the past five years, yet the country currently has only 11 factories dedicated to pharmaceutical manufacturing, with local production meeting just 10–20% of national demand — meaning up to 80% of all drugs and medical supplies are imported. In December 2025, the Government of Tanzania announced a formal policy shift to accelerate domestic pharmaceutical manufacturing, with the objective of positioning the country as a regional pharmaceutical manufacturing hub — planning 10 new factories for ARVs, tablets, injectables, drips and reagents, and creating massive demand for new GMP-compliant production facilities, equipment, and turnkey factory infrastructure.

Market Demand

Demand Trends Within the Country

  • National Pharmaceutical Localization Push

    The Government has introduced a Green-Lane Approval System under the Pharmaceutical Investment Acceleration Programme to fast-track strategic pharmaceutical investments, driving urgent demand for new production lines and complete factory builds
  • Injectable & IV Solution Production

    With a population of ~65 million and expanding healthcare infrastructure, Tanzania critically needs locally produced IV fluids, injectable antibiotics, antimalarials, ARVs, and vaccines to replace its massive import bill.
  • OSD & Generic Drug Manufacturing

    The growth of the generic drug segment is a major market trend, driven by the government’s efforts to increase access to affordable healthcare and policies encouraging the use of generic drugs in public health facilities.
  • Medical Consumables & Diagnostics

    The government initiative explicitly targets local production of essential medicines, vaccines, biologics, APIs, medical consumables, and specialized formulations — creating demand for locally assembled blood collection tubes, syringes, and blood bags.

Our Local Expertise

Local Experience, Reliable Execution

  • Proven East Africa delivery track record — 2,500+ production lines deployed in 60+ countries, with deep experience across Sub-Saharan African pharmaceutical and medical device markets, including completed projects in Tanzania.

  • TMDA & WHO GMP alignment — All systems pre-engineered to meet WHO GMP, EU GMP, and PIC/S GMP standards, fully aligned with TMDA inspection requirements. Tanzania made history in 2018 when TMDA became the first regulatory authority in Africa to attain WHO Maturity Level 3 status, and our systems are designed to meet this benchmark.

  • Full turnkey EPC capability — From consulting and process design through equipment manufacturing, cleanroom construction, utility installation, IQ/OQ/PQ validation, technology transfer, and operator training — one partner, one contract.

  • Customized for Tanzania’s strategic priorities — Solutions tailored for high-burden therapeutic areas (HIV/AIDS, malaria, TB, infectious diseases) and configured to support the government’s regional pharmaceutical hub ambitions targeting EAC and SADC export markets.

Recommended Products

Selected Products for This Market

Compliance & Logistics

Meeting Local Standards with Reliable Delivery

Compliance & Certification

  • All equipment complies with EU GMP, US FDA cGMP, WHO GMP, and PIC/S GMP — fully aligned with SFDA GMP inspection requirements

  • Complete IQ/OQ/PQ validation documentation packages provided for streamlined SFDA facility approval and GMP licensing

  • Engineering designs support Vision 2030 localization targets and NUPCO guaranteed offtake procurement eligibility

Logistics & Delivery

  • Direct shipping to Dar es Salaam Port with full export documentation and customs support

  • On-site installation, commissioning, and validation by IVEN’s international engineering teams across mainland Tanzania

  • Comprehensive technology transfer and hands-on operator training programs for Tanzanian production staff

case

Success Snapshot

  • Pharmaceutical Manufacturer

    Dar es Salaam, Tanzania

    Delivered a PP bottle IV solution production line with pharmaceutical water system, cleanroom, and automated packaging. The facility passed TMDA GMP inspection and achieved annual production of 10 million bottles of IV solution, supplying MSD and private-sector distribution channels across the country.

  • Healthcare Investment Group

    Healthcare Investment Group

    Supplied an integrated OSD plant including tablet and capsule lines, purified water system, and blister packaging for production of antimalarials, antibiotics, and essential generics. The project was completed in 15 months, achieving TMDA GMP certification and enabling the client to serve both the domestic market and EAC regional export.

testimony

Trusted by Local Customers

  • “IVEN delivered our complete IV solution facility — water system, cleanroom, filling line, and packaging — under one turnkey contract. Their understanding of TMDA requirements and WHO GMP standards meant we passed inspection on the first audit and were producing within 14 months.”

    Mr. M

    Managing Director

  • “Their OSD factory solution was exactly what we needed to support Tanzania’s essential medicines program. The technology transfer and staff training were exceptionally thorough — our Tanzanian operators were fully independent within weeks.”

    Dr. J

    Plant Director

Support

FAQ

Yes. All systems are designed to meet WHO GMP, EU GMP, and PIC/S GMP standards, which are fully aligned with TMDA’s WHO Maturity Level 3 inspection framework — the highest regulatory benchmark in Africa.

Absolutely. We provide full turnkey EPC services — from facility design and equipment manufacturing to installation, validation, and technology transfer — enabling investors to meet the government’s fast-track pharmaceutical industrialization requirements.

Single production lines are typically delivered in 8–12 months; complete turnkey factories in 14–22 months from contract to validated commercial production, including shipping to Dar es Salaam and on-site installation.

Yes — including preventive maintenance programs, remote technical support, spare parts supply with direct shipping to Dar es Salaam, and on-site service visits by our engineering teams.

Yes. We design scalable facilities that meet international GMP standards for both the Tanzanian market and export to EAC, SADC, and broader African markets — aligned with Tanzania’s ambition to become a regional pharmaceutical manufacturing hub.

Related Market Solutions